GOVX
GeoVax Labs, Inc.Company with tickers: GOVX
CIK
832489
CUSIP
373678705
Shares Outstanding
2,223,577
Price
Holdings
Short Volume
Short Interest
Fails to Deliver
SEC Filings
Earnings Calls
Insider Trading
Congress Trades
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2025-10-17 | SPENCER JOHN N JR | Director | Buy | 10,000 |
| 2025-08-07 | McKee Kelly T. Jr. | Chief Medical Officer | Buy | 1,107 |
| 2025-06-05 | CHASE RANDAL D | Director | Award | 10,000 |
| 2025-06-05 | MCNALLY ROBERT T | Director | Award | 10,000 |
| 2025-06-05 | SPENCER JOHN N JR | Director | Award | 10,000 |
| 2025-06-05 | Lemerond Nicole | Director | Award | 10,000 |
| 2025-06-05 | Kollintzas Dean G | Director | Award | 10,000 |
| 2025-06-05 | Morgan Jayne | Director | Award | 10,000 |
| 2025-06-05 | NEWMAN MARK J | Chief Scientific Officer | Award | 70,000 |
| 2025-06-05 | McKee Kelly T. Jr. | Chief Medical Officer | Award | 70,000 |
| 2025-06-05 | Sharkey John W. | VP, Business Development | Award | 70,000 |
| 2025-06-05 | Reynolds Mark | CFO | Award | 70,000 |
| 2025-06-05 | DODD DAVID A | Director, President, CEO | Award | 185,500 |
| 2025-04-10 | SPENCER JOHN N JR | Director | Buy | 10,000 |
| 2025-04-10 | Sharkey John W. | VP, Business Development | Buy | 6,000 |
| 2025-04-01 | DODD DAVID A | Director, President, CEO | Buy | 10,000 |
| 2025-03-31 | Reynolds Mark | CFO | Buy | 6,800 |
| 2024-08-12 | DODD DAVID A | Director, President, CEO | Award | 35,000 |
| 2024-08-12 | McKee Kelly T. Jr. | Chief Medical Officer | Award | 15,700 |
| 2024-08-12 | NEWMAN MARK J | Chief Scientific Officer | Award | 15,700 |
| 2024-08-12 | Sharkey John W. | VP, Business Development | Award | 15,700 |
| 2024-08-12 | CHASE RANDAL D | Director | Award | 8,050 |
| 2024-08-12 | Kollintzas Dean G | Director | Award | 8,050 |
| 2024-08-12 | Morgan Jayne | Director | Award | 8,050 |
| 2024-08-12 | Reynolds Mark | CFO | Award | 15,700 |
| 2024-08-12 | Lemerond Nicole | Director | Award | 8,050 |
| 2024-08-12 | MCNALLY ROBERT T | Director | Award | 8,050 |
| 2024-08-12 | SPENCER JOHN N JR | Director | Award | 8,050 |
| 2024-08-09 | DODD DAVID A | Director, President, CEO | Buy | 8,000 |
| 2024-02-22 | DODD DAVID A | Director, President, CEO | Buy | 8,209 |
| 2024-02-21 | DODD DAVID A | Director, President, CEO | Buy | 520 |
| 2024-02-07 | Reynolds Mark | CFO | Buy | 2,000 |
| 2023-12-22 | McKee Kelly T. Jr. | Chief Medical Officer | Buy | 6,944 |
| 2023-09-25 | McKee Kelly T. Jr. | Chief Medical Officer | Buy | 9,653 |
| 2023-08-25 | DODD DAVID A | Director, President, CEO | Buy | 35,087 |
| 2023-08-18 | Reynolds Mark | CFO | Buy | 10,000 |
| 2023-08-01 | Lemerond Nicole | Director | Award | 50,000 |
| 2023-08-01 | Sharkey John W. | VP, Business Development | Award | 100,000 |
| 2023-08-01 | SPENCER JOHN N JR | Director | Award | 50,000 |
| 2023-08-01 | Morgan Jayne | Director | Award | 50,000 |
| 2023-08-01 | MCNALLY ROBERT T | Director | Award | 50,000 |
| 2023-08-01 | Kollintzas Dean G | Director | Award | 50,000 |
| 2023-08-01 | CHASE RANDAL D | Director | Award | 50,000 |
| 2023-08-01 | McKee Kelly T. Jr. | Chief Medical Officer | Award | 15,000 |
| 2023-08-01 | NEWMAN MARK J | Chief Scientific Officer | Award | 100,000 |
| 2023-08-01 | DODD DAVID A | Director, President, CEO | Award | 250,000 |
| 2023-08-01 | Reynolds Mark | CFO | Award | 100,000 |
| 2023-04-24 | DODD DAVID A | Director, President, CEO | Buy | 32,000 |
| 2023-04-20 | Reynolds Mark | CFO | Buy | 8,000 |
| 2022-12-07 | Morgan Jayne | Director | Other | 0 |
| 2022-09-21 | CHASE RANDAL D | Director | Buy | 10,000 |
| 2022-08-31 | Lemerond Nicole | Director | Other | 0 |
| 2022-07-01 | Sharkey John W. | VP, Business Development | Buy | 1,000 |
| 2022-06-27 | McKee Kelly T. Jr. | Chief Medical Officer | Buy | 4,464 |
| 2022-06-21 | CHASE RANDAL D | Director | Buy | 10,000 |
| 2022-06-13 | Sharkey John W. | VP, Business Development | Other | 1,860 |
| 2022-06-13 | Sharkey John W. | VP, Business Development | Other | 0 |
| 2022-05-05 | McKee Kelly T. Jr. | Chief Medical Officer | Buy | 9,722 |
| 2022-05-04 | McKee Kelly T. Jr. | Chief Medical Officer | Buy | 4,999 |
| 2022-01-06 | McKee Kelly T. Jr. | Chief Medical Officer | Other | 0 |
| 2021-12-07 | Kollintzas Dean G | Director | Award | 25,000 |
| 2021-12-07 | DODD DAVID A | Director, President, CEO | Award | 103,000 |
| 2021-12-07 | Reynolds Mark | CFO | Award | 48,200 |
| 2021-12-07 | SPENCER JOHN N JR | Director | Award | 25,000 |
| 2021-12-07 | MCNALLY ROBERT T | Director | Award | 25,000 |
| 2021-12-07 | NEWMAN MARK J | Chief Scientific Officer | Award | 25,700 |
| 2021-12-07 | CHASE RANDAL D | Director | Award | 25,000 |
| 2021-08-11 | CHASE RANDAL D | Director | Award | 25,000 |
| 2021-08-11 | MCNALLY ROBERT T | Director | Award | 25,000 |
| 2021-08-11 | DODD DAVID A | Director, President, CEO | Award | 273,000 |
| 2021-08-11 | Kollintzas Dean G | Director | Award | 25,000 |
| 2021-08-11 | NEWMAN MARK J | Chief Scientific Officer | Award | 35,000 |
| 2021-08-11 | SPENCER JOHN N JR | Director | Award | 25,000 |
| 2021-08-11 | Reynolds Mark | CFO | Award | 128,000 |
| 2020-09-29 | CHASE RANDAL D | Director | Buy | 16,613 |
| 2020-09-29 | CHASE RANDAL D | Director | Buy | 16,613 |
| 2020-09-29 | Kollintzas Dean G | Director | Buy | 11,987 |
| 2020-09-29 | Kollintzas Dean G | Director | Buy | 11,987 |
| 2020-09-29 | SPENCER JOHN N JR | Director | Buy | 21,024 |
| 2020-09-29 | SPENCER JOHN N JR | Director | Buy | 21,024 |
| 2020-09-29 | MCNALLY ROBERT T | Director | Buy | 53,925 |
| 2020-09-29 | MCNALLY ROBERT T | Director | Buy | 53,925 |
| 2020-09-29 | DODD DAVID A | Director, President, CEO | Buy | 81,870 |
| 2020-09-29 | DODD DAVID A | Director, President, CEO | Buy | 81,870 |
| 2020-09-29 | Reynolds Mark | CFO | Buy | 60,184 |
| 2020-09-29 | Reynolds Mark | CFO | Buy | 60,184 |
| 2020-08-25 | NEWMAN MARK J | Chief Scientific Officer | Other | 0 |